176 related articles for article (PubMed ID: 10834541)
1. Overexpression of cyclin D1 in nonmelanocytic skin cancer.
Liang SB; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H; Ohtsuki Y
Virchows Arch; 2000 Apr; 436(4):370-6. PubMed ID: 10834541
[TBL] [Abstract][Full Text] [Related]
2. Sun-exposure- and aging-dependent p53 protein accumulation results in growth advantage for tumour cells in carcinogenesis of nonmelanocytic skin cancer.
Liang SB; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H
Virchows Arch; 1999 Mar; 434(3):193-9. PubMed ID: 10190297
[TBL] [Abstract][Full Text] [Related]
3. [Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma].
Wang Q; Ma H; Wang S; Ma Y; Zou X; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1075-7. PubMed ID: 23895857
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
[TBL] [Abstract][Full Text] [Related]
5. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
6. Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma.
Liang SB; Furihata M; Takeuchi T; Sonobe H; Ohtsuki Y
Virchows Arch; 2001 Nov; 439(5):622-7. PubMed ID: 11764381
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
8. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
9. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
Hida Y; Kubo Y; Murao K; Arase S
Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
[No Abstract] [Full Text] [Related]
11. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
[TBL] [Abstract][Full Text] [Related]
12. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of cyclooxygenase-2 and p53 expression in skin tumors.
Kim KH; Park EJ; Seo YJ; Cho HS; Kim CW; Kim KJ; Park HR
J Dermatol; 2006 May; 33(5):319-25. PubMed ID: 16700663
[TBL] [Abstract][Full Text] [Related]
15. Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer.
Mancuso M; Gallo D; Leonardi S; Pierdomenico M; Pasquali E; De Stefano I; Rebessi S; Tanori M; Scambia G; Di Majo V; Covelli V; Pazzaglia S; Saran A
Carcinogenesis; 2009 Feb; 30(2):340-7. PubMed ID: 18952596
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues.
Wu J; Lu WY; Cui LL
Mol Med Rep; 2015 Dec; 12(6):8129-34. PubMed ID: 26497194
[TBL] [Abstract][Full Text] [Related]
17. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
[TBL] [Abstract][Full Text] [Related]
19. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma.
Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA
Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
